Fields of research:
Cardiology, drug therapy, heart failure, pulmonary hypertension, immunosuppression, heart transplantation, mechanical assist devices, real time pulmonary artery pressure monitoring
Research Interests:
Pulmonary hypertension, primary and secondary, early diagnosis and treatment, upfront combination therapies with agents with varied mechanisms of effect. Phase II, III and IV trials. Real time pulmonary artery pressure monitoring including First in Man (planned for late 2015). Non invasive impedance cardiac output monitoring for intrapatient changes in response to therapy.
Left heart failure: pharmacological, electrical and mechanical therapy tailored to the individual
Immunosuppression after heart transplantation, tailoring therapy to the individual
Tissue banking to utilise unneeded human tissue for research correlating with deidentified clinical data (genetics of familial cardiomyopathy and of pulmonary hypertension) and to improve access by researchers to human tissue with the goal to reduce usage of animals and animal products
Data basing: Director of ANZCOTR (Australia and New Zealand Cardiothoracic Organ Transplant Registry) and Director of PHSANZ (Pulmonary Hypertension Society of Australia and New Zealand)
Guidelines writing (World Society for PH)
Qualifications:
MBBS (Hons), MD, FRACP, FCSANZ, FPVRI
Societies Memberships and Professional Activities
Cardiac Society of ANZ
Transplant Society of ANZ
RACP
International Society for heart and Lung Transplanation (ex-President 2000)
Pulmonary Hypertension Society of Australia and New Zealand (Founder and Inaugural President)
Pulmonary Vascular Research Institute
Medical Advancces Without Animals (Trustee MAWA 2003-2015)
Links
www.victorchang.edu.au
www.phsanz.com.au
www.anzcotr.org.au
